{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:41:58Z","timestamp":1788892918168,"version":"build-2803163510"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Blair Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Background\/Objectives: Peripheral artery disease (PAD) is associated with an increased risk of major adverse cardiovascular events (MACE), such as myocardial infarction and stroke, which are the top mortality causes in the PAD population. However, the identification of reliable biomarkers for predicting MACE in PAD patients remains limited. Proteins involved in extracellular matrix (ECM) remodeling have been implicated in atherosclerosis and may serve as potential indicators of cardiovascular risk. This study aimed to evaluate a panel of circulating proteins involved in ECM remodeling to identify those predictive of 2-year MACE in individuals with PAD. Methods: A prospective cohort of 465 PAD patients was enrolled and followed for 24 months. At baseline, plasma levels of nine ECM-related proteins were quantified. The outcome of interest was a 2-year MACE, defined as a composite of myocardial infarction, stroke, or mortality. Protein level differences between MACE vs. non-MACE patients were analyzed using Mann\u2013Whitney U tests. Cox proportional hazards models, adjusted for baseline variables (including known cerebrovascular and coronary disease), were used to determine the independent associations between each protein and 2-year MACE. Subgroup analyses were conducted for diabetic and female patients, who are known to be at high risk for adverse events. Results: The mean age of the participants was 71 (SD 10) years, with 31.1% identifying as female and 47.2% having diabetes. Over two years, 84 patients (18.1%) experienced MACE. Among the proteins analyzed, matrix metalloproteinase-10 (MMP-10) and matrix metalloproteinase-7 (MMP-7) were significantly elevated in those who developed MACE compared to those who did not: MMP-10 (710.60 pg\/mL [SD 46.09] vs. 672.40 pg\/mL [SD 45.04], p = 0.032) and MMP-7 (5.20 pg\/mL [SD 4.11] vs. 4.76 pg\/mL [SD 3.86], p = 0.048). Both independently correlated with 2-year MACE after adjustment for all baseline factors: MMP-10 (HR 1.32, 95% CI 1.16\u20131.51, p = 0.023) and MMP-7 (HR 1.17, 95% CI 1.05\u20132.68, p = 0.026). Subgroup analyses revealed that MMP-10 was associated with MACE in diabetic patients (HR 1.18, 95% CI 1.13\u20131.53, p = 0.019), while MMP-7 was associated with MACE among females (HR 1.31, 95% CI 1.15\u20131.69, p = 0.009). Conclusions: MMP-10 and MMP-7 emerged as independent biomarkers for prognosticating 2-year MACE in PAD patients, suggesting their utility in systemic cardiovascular risk stratification. Measuring these proteins could enhance clinical decision-making by identifying high-risk individuals with PAD who may benefit from multidisciplinary vascular evaluation and intensified treatment strategies, ultimately aiming to reduce cardiovascular complications in the PAD population.<\/jats:p>","DOI":"10.3390\/biom15060853","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:23:16Z","timestamp":1749619396000},"page":"853","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Matrix Metalloproteinases 7 and 10 Are Prognostic Biomarkers for Systemic Cardiovascular Risk in Individuals with Peripheral Artery Disease"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-1034","authenticated-orcid":false,"given":"Ben","family":"Li","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Division of Vascular Surgery, St. Michael\u2019s Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM), University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, St. Michael\u2019s Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houssam","family":"Younes","sequence":"additional","affiliation":[{"name":"Heart, Vascular, & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi P.O. Box 112412, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batool","family":"Abuhalimeh","sequence":"additional","affiliation":[{"name":"Heart, Vascular, & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi P.O. Box 112412, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Zamzam","sequence":"additional","affiliation":[{"name":"Division of Vascular Surgery, St. Michael\u2019s Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawand","family":"Abdin","sequence":"additional","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Qadura","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Division of Vascular Surgery, St. Michael\u2019s Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Heart, Vascular, & Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi P.O. Box 112412, United Arab Emirates"},{"name":"Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Unity Health Toronto, University of Toronto, Toronto, ON M5B 1W8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4065\/mcp.2010.0133","article-title":"Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management","volume":"85","author":"Olin","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Horv\u00e1th, L., N\u00e9meth, N., Feh\u00e9r, G., K\u00edv\u00e9s, Z., Endrei, D., and Boncz, I. (2022). Epidemiology of Peripheral Artery Disease: Narrative Review. Life, 12.","DOI":"10.3390\/life12071041"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1358863X13493825","article-title":"Peripheral Artery Disease and Risk of Cardiovascular Events in Patients with Coronary Artery Disease: Insights from the Heart and Soul Study","volume":"18","author":"Grenon","year":"2013","journal-title":"Vasc. Med."},{"key":"ref_4","first-page":"e30119","article-title":"A Systematic Review of Major Cardiovascular Risk Factors: A Growing Global Health Concern","volume":"14","author":"Adhikary","year":"2022","journal-title":"Cureus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2047487317709118","article-title":"A Multidisciplinary Approach to Prevention","volume":"24","author":"Jennings","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Li, B., Zamzam, A., Syed, M.H., Jahanpour, N., Jain, S., Abdin, R., and Qadura, M. (2022). Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.875244"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jvs.2023.05.001","article-title":"Fatty Acid Binding Protein 4 Has Prognostic Value in Peripheral Artery Disease","volume":"78","author":"Li","year":"2023","journal-title":"J. Vasc. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Di Nubila, A., Dilella, G., Simone, R., and Barbieri, S.S. (2024). Vascular Extracellular Matrix in Atherosclerosis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212017"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MOL.0000000000000775","article-title":"Extracellular Matrix: Paving the Way to the Newest Trends in Atherosclerosis","volume":"32","author":"Gialeli","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"25B","DOI":"10.1016\/S0828-282X(06)70983-7","article-title":"Matrix Metalloproteinases in Cardiovascular Disease","volume":"22","author":"Liu","year":"2006","journal-title":"Can. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ddmod.2011.02.001","article-title":"Metalloproteinases in Hypertension and Cardiac Disease: Differential Expression and Mutual Regulation","volume":"8","author":"Bosonea","year":"2011","journal-title":"Drug Discov. Today Dis. Models"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.matbio.2017.12.001","article-title":"Understanding Cardiac Extracellular Matrix Remodeling to Develop Biomarkers of Myocardial Infarction Outcomes","volume":"75\u201376","author":"Nielsen","year":"2019","journal-title":"Matrix Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Trinh, K., Julovi, S.M., and Rogers, N.M. (2022). The Role of Matrix Proteins in Cardiac Pathology. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031338"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","article-title":"Extracellular Matrix Remodeling and Cardiac Fibrosis","volume":"68\u201369","author":"Li","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"H1687","DOI":"10.1152\/ajpheart.00631.2018","article-title":"Extracellular Matrix in Cardiovascular Pathophysiology","volume":"315","author":"Bloksgaard","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100706","DOI":"10.1016\/j.mcpro.2023.100706","article-title":"Remodeling of the Cardiac Extracellular Matrix Proteome During Chronological and Pathological Aging","volume":"23","author":"Santinha","year":"2024","journal-title":"Mol. Cell Proteom."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Li, B., Nassereldine, R., Shaikh, F., Younes, H., AbuHalimeh, B., Zamzam, A., Abdin, R., and Qadura, M. (2024). Inflammatory Protein Panel: Exploring Diagnostic Insights for Peripheral Artery Disease Diagnosis in a Cross-Sectional Study. Diagnostics, 14.","DOI":"10.3390\/diagnostics14171847"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.2147\/JIR.S471150","article-title":"Prediction of Peripheral Artery Disease Prognosis Using Clinical and Inflammatory Biomarker Data","volume":"17","author":"Li","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"World Medical Association (2013). World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI Statement: Updated Guidance for Reporting Clinical Prediction Models That Use Regression or Machine Learning Methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"ref_21","unstructured":"Gul, F., and Janzer, S.F. (2021). Peripheral Vascular Disease. StatPearls, StatPearls Publishing."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","unstructured":"(2023, May 06). Luminex Assays, Multiplex Immunoassays. Available online: https:\/\/www.bio-techne.com\/."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JCM.01979-16","article-title":"Development of a Sensitive and Specific Serological Assay Based on Luminex Technology for Detection of Antibodies to Zaire Ebola Virus","volume":"55","author":"Ayouba","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/CVI.00354-07","article-title":"Profiling Antibodies to Mycobacterium Tuberculosis by Multiplex Microbead Suspension Arrays for Serodiagnosis of Tuberculosis","volume":"15","author":"Khan","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymeth.2019.02.008","article-title":"Use and Reliability of Multiplex Bead-Based Assays (Luminex) at Containment Level 4","volume":"158","author":"Dowall","year":"2019","journal-title":"Methods"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Roy, D.R., Kemp, T.J., Haynesworth, K., Loftus, S.A., and Pinto, L.A. (2023). Development, Validation, and Utilization of a Luminex-Based SARS-CoV-2 Multiplex Serology Assay. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.03898-22"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2011.01.010","article-title":"Development and Evaluation of a Luminex Multiplex Serology Assay to Detect Antibodies to Bovine Herpes Virus 1, Parainfluenza 3 Virus, Bovine Viral Diarrhoea Virus, and Bovine Respiratory Syncytial Virus, with Comparison to Existing ELISA Detection Methods","volume":"366","author":"Anderson","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4939-6730-8_13","article-title":"Multiplex Immunoassay Profiling","volume":"1546","author":"Stephen","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"113472","DOI":"10.1016\/j.jim.2023.113472","article-title":"Comparative Evaluation of Luminex Based Assays for Detection of SARS-CoV-2 Antibodies in a Transplantation Laboratory","volume":"517","author":"Cox","year":"2023","journal-title":"J. Immunol. Methods"},{"key":"ref_32","unstructured":"(2021, December 18). MAGPIX\u00ae System|xMAP Instrument|Luminex Corporation. Available online: https:\/\/www.luminexcorp.com\/magpix-system\/."},{"key":"ref_33","unstructured":"(2021, December 18). Luminex Assays-CA. Available online: http:\/\/www.thermofisher.com\/ca\/en\/home\/life-science\/antibodies\/immunoassays\/procartaplex-assays-luminex.html."},{"key":"ref_34","first-page":"e618","article-title":"The Executive Group on behalf of the Joint European Society of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction Fourth Universal Definition of Myocardial Infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Draper, K., Li, B., Syed, M., Shaikh, F., Zamzam, A., Abuhalimeh, B.J., Rasheed, K., Younes, H.K., Abdin, R., and Qadura, M. (2025). Identification of Inflammatory Biomarkers for Predicting Peripheral Arterial Disease Prognosis in Patients with Diabetes. Diabetology, 6.","DOI":"10.3390\/diabetology6010002"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12265-024-10574-y","article-title":"Prediction of Major Adverse Limb Events in Females with Peripheral Artery Disease Using Blood-Based Biomarkers and Clinical Features","volume":"18","author":"Li","year":"2024","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_38","first-page":"342","article-title":"A Hidden Problem: Peripheral Artery Disease in Women","volume":"9","author":"Kavurma","year":"2023","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_39","unstructured":"(2021, December 18). SPSS Software. Available online: https:\/\/www.ibm.com\/analytics\/spss-statistics-software."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jvs.2014.09.002","article-title":"Matrix Metalloproteinase 10 Is Associated with Disease Severity and Mortality in Patients with Peripheral Arterial Disease","volume":"61","author":"Orbe","year":"2015","journal-title":"J. Vasc. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/ATVBAHA.120.314143","article-title":"A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis","volume":"40","author":"Matilla","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.avsg.2023.04.029","article-title":"Serum Levels of Matrix Metalloproteinases in Patients Undergoing Endovascular Intervention for Peripheral Arterial Disease","volume":"94","author":"Giagtzidis","year":"2023","journal-title":"Ann. Vasc. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1096\/fasebj.12.12.1075","article-title":"Matrix Metalloproteinases: Structures, Evolution, and Diversification","volume":"12","author":"Massova","year":"1998","journal-title":"FASEB J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0021-9150(03)00251-X","article-title":"Different Expression of MMPs\/TIMP-1 in Human Atherosclerotic Lesions. Relation to Plaque Features and Vascular Bed","volume":"170","author":"Orbe","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2018.09.022","article-title":"Matrix Metalloproteinase-10 Deficiency Delays Atherosclerosis Progression and Plaque Calcification","volume":"278","author":"Purroy","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Abbas, A., Aukrust, P., Russell, D., Krohg-S\u00f8rensen, K., Alm\u00e5s, T., Bundgaard, D., Bjerkeli, V., Sagen, E.L., Michelsen, A.E., and Dahl, T.B. (2014). Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084935"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"bjgp20X711605","DOI":"10.3399\/bjgp20X711605","article-title":"Blood Tests in General Practice: The Use of Routine Data to Characterise Venous Blood Testing in North West London, 2016-2018","volume":"70","author":"Bakhet","year":"2020","journal-title":"Br. J. Gen. Pract."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1016\/j.jacc.2015.05.014","article-title":"Vascular Medicine","volume":"65","author":"Cameron","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/fampra\/cmad048","article-title":"Peripheral Artery Disease (PAD) in Primary Care-Educational Experiences for PAD Primary Care in England-a Mixed-Method Study","volume":"40","author":"Bridgwood","year":"2023","journal-title":"Fam. Pract."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","article-title":"PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week","volume":"73","author":"Doenst","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jvs.2019.09.054","article-title":"Characteristics of High-Cost Inpatients with Peripheral Artery Disease","volume":"72","author":"Rockley","year":"2020","journal-title":"J. Vasc. Surg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijcard.2020.09.053","article-title":"Predicting 10-Year Risk of Recurrent Cardiovascular Events Andcardiovascular Interventions in Patients with Established Cardiovascular Disease: Results from UCC-SMART and REACH","volume":"325","author":"Bhatt","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/clc.22839","article-title":"Antithrombotic Therapy in Peripheral Artery Disease: A Review of the EUCLID Trial Results and Current Ongoing Trials","volume":"41","author":"Ward","year":"2018","journal-title":"Clin. Cardiol."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/6\/853\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:49:55Z","timestamp":1760032195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/6\/853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["biom15060853"],"URL":"https:\/\/doi.org\/10.3390\/biom15060853","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}